|
Volumn 295, Issue 5562, 2002, Pages 2042-2046
|
Erasing the world's slow stain: Strategies to beat multidrug-resistant tuberculosis
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CHEMOTHERAPY;
DRUG DOSAGE;
HEALTH HAZARDS;
STRATEGIC PLANNING;
FEASIBILITY;
DISEASE CONTROL;
BACTERIAL DNA;
ISONIAZID;
RIFAMPICIN;
TUBERCULOSTATIC AGENT;
DISEASE CONTROL;
DISEASE INCIDENCE;
DRUG RESISTANCE;
EPIDEMIOLOGY;
TUBERCULOSIS;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG SAFETY;
ENDEMIC DISEASE;
EPIDEMIC;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MULTIDRUG RESISTANCE;
MYCOBACTERIUM TUBERCULOSIS;
PRIORITY JOURNAL;
RESTRICTION FRAGMENT LENGTH POLYMORPHISM;
REVIEW;
SHORT COURSE THERAPY;
TUBERCULOSIS;
TUBERCULOSIS CONTROL;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANTITUBERCULAR AGENTS;
DRUG RESISTANCE, MULTIPLE, BACTERIAL;
DRUG THERAPY, COMBINATION;
HIV INFECTIONS;
HUMANS;
INCIDENCE;
MYCOBACTERIUM TUBERCULOSIS;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
WORLD HEALTH;
ACTINOBACTERIA (CLASS);
BACTERIA (MICROORGANISMS);
HUMAN IMMUNODEFICIENCY VIRUS;
MYCOBACTERIUM;
MYCOBACTERIUM TUBERCULOSIS;
UNCULTURED ACTINOMYCETE;
|
EID: 0037086354
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.1063814 Document Type: Review |
Times cited : (306)
|
References (53)
|